Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

Information about the relationship between pharmacological parameters and an early virological response to tipranavir (TPV) is scarce. Human immunodeficiency virus (HIV)-infected patients who had received TPV as part of a salvage regimen were analyzed retrospectively. A virological response was defi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Morello, Judit, De Mendoza, Carmen, Soriano, Vincent, Anta, Lourdes, González-Pardo, Gema, Corral, Angélica, Blanco, Francisco, Jiménez-Nácher, Inmaculada, González-Lahoz, Juan, Rodríguez-Novoa, Sonia
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2009
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764193/
https://ncbi.nlm.nih.gov/pubmed/19596874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00041-09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares